Neuroprotective effect of luteolin on amyloid β protein (25–35)‐induced toxicity in cultured rat cortical neurons

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Phytotherapy Research

• Publication date

  2010-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ptr.2940PMID 19610032
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Green tea polyphenol (−)-epigallocatechin-3-gallate protects rat PC12 cells from apoptosis induced by serum withdrawal

  2009cited by this paper
• Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer’s disease

  2007cited by this paper
• Effects of luteolin on learning acquisition in rats: involvement of the central cholinergic system.

  2007cited by this paper
• Treadmill running reverses retention deficit induced by morphine.

  2006cited by this paper
• Luteolin, a flavonoid, inhibits AP-1 activation by basophils.

  2006cited by this paper
• Down-regulation of glutaredoxin by estrogen receptor antagonist renders female mice susceptible to excitatory amino acid mediated complex I inhibition in CNS.

  2006cited by this paper
• Dissociated primary nerve cell cultures as models for assessment of neurotoxicity.

  2006cited by this paper
• Soy isoflavones and cognitive function.

  2005cited by this paper
• Olanzapine produces trophic effects in vitro and stimulates phosphorylation of Akt/PKB, ERK1/2, and the mitogen-activated protein kinase p38.

  2004cited by this paper
• Antioxidant compounds from Chaerophyllum hirsutum extracts.

  2004cited by this paper
• Neutralization of TRAIL death pathway protects human neuronal cell line from β-amyloid toxicity

  2003cited by this paper
• Green tea polyphenol (-)-epigallocatechin-3-gallate protects rat PC12 cells from apoptosis induced by serum withdrawal independent of P13-Akt pathway.

  2003cited by this paper
• Alzheimer beta-amyloid peptides: normal and abnormal localization.

  2002cited by this paper
• Antagonism of NMDA receptors by sigma receptor ligands attenuates chemical ischemia-induced neuronal death in vitro.

  2002cited by this paper
• 17β-Estradiol and the phytoestrogen genistein attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium-ATPase inhibitor thapsigargin

  2002cited by this paper
• Inhibition of LPS‐stimulated pathways in macrophages by the flavonoid luteolin

  2002cited by this paper
• Induction of cytochrome c-mediated apoptosis by amyloid beta 25-35 requires functional mitochondria.

  2002cited by this paper
• Study of antioxidant effect of apigenin, luteolin and quercetin by DNA protective method.

  2001cited by this paper
• Involvement of direct inhibition of NMDA receptors in the effects of sigma-receptor ligands on glutamate neurotoxicity in vitro.

  2000cited by this paper
• Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human.

  1999cited by this paper
• Hormone replacement therapy and Alzheimer's disease.

  1999cited by this paper
• Changes in caspase expression in Alzheimer's disease: comparison with development and aging.

  1999cited by this paper
• Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis‐associated properties in A431 cells overexpressing epidermal growth factor receptor

  1999cited by this paper
• Flavonoids: Dietary occurrence and biochemical activity

  1998cited by this paper
• The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival.

  1998cited by this paper
• The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.

  1998cited by this paper
• Lasting N-Terminal Phosphorylation of c-Jun and Activation of c-Jun N-Terminal Kinases after Neuronal Injury

  1998cited by this paper
• Luteolin-rich artichoke extract protects low density lipoprotein from oxidation in vitro.

  1998cited by this paper
• Anti-apoptotic versus pro-apoptotic signal transduction: Checkpoints and stop signs along the road to death

  1998cited by this paper
• Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes.

  1998cited by this paper
• Lymphocytes as cell model to study apoptosis in Alzheimer's disease: vulnerability to programmed cell death appears to be altered.

  1998cited by this paper
• Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites.

  1998cited by this paper
• Amyloid β-peptide induces apoptosis-related events in synapses and dendrites

  1998cited by this paper
• Caspases: killer proteases.

  1997cited by this paper
• Protective effect of flavonoids on doxorubicin-induced cardiotoxicity.

  1997cited by this paper
• Attenuation of p53 expression and Bax down‐regulation during phorbol ester mediated inhibition of apoptosis

  1997cited by this paper
• Biochemical and Temporal Analysis of Events Associated with Apoptosis Induced by Lowering the Extracellular Potassium Concentration in Mouse Cerebellar Granule Neurons

  1997cited by this paper
• Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis.

  1997cited by this paper
• Sounding the Alarm: Protein Kinase Cascades Activated by Stress and Inflammation*

  1996cited by this paper
• Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice

  1996cited by this paper
• Estrogen and apoptosis in the developing sexually dimorphic preoptic area in female rats.

  1996cited by this paper
• Preliminary assessment of luteolin as an affinity ligand for type II estrogen--binding sites in rat uterine nuclear extracts.

  1993cited by this paper
• Alzheimer's disease: a disorder of cortical cholinergic innervation.

  1983cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• DOĞAL KAYNAKLARIN DİYABETİK NÖROPATİ TEDAVİSİNDEKİ ROLÜ

  2026cites this paper
• Polystyrene nanoplastics exposure trigger cognitive impairment mitigated by luteolin modulated glucose-6-phosphate dehydrogenase/glutathione-dependent pathway.

  2025cites this paper
• Attenuation of cannabis withdrawal symptoms by Prosopis farcta extract, its luteolin and melatonin in mice: Involvement of brain‐derived neurotrophic factor and dopamine

  2024cites this paper
• Luteolin Ameliorating Effects of Endoplasmic Reticulum Stress and Mitochondrial Dysfunction in an ASD Rodent Model

  2024cites this paper
• Luteolin as potential treatment for Huntington's disease: Insights from a transgenic mouse model

  2024cites this paper
• Luteolin promotes pathogen resistance in Caenorhabditis elegans via DAF-2/DAF-16 insulin-like signaling pathway.

  2023cites this paper
• A clinical study and future prospects for bioactive compounds and semi-synthetic molecules in the therapies for Huntington's disease

  2023cites this paper
• Advances in Alzheimer’s disease therapeutics: biochemistry, exploring bioactive compounds and novel approaches

  2023cites this paper
• Sideritis scardica Extracts Demonstrate Neuroprotective Activity against Aβ25–35 Toxicity

  2023cites this paper
• Novel Nutraceutical Compounds in Alzheimer Prevention

  2022cites this paper
• The Effect of Prosopis farcta and Its Bioactive Luteolin on the Hippocampus of Mice after Induced Ischemia Reperfusion

  2022cites this paper
• Dietary and nutraceutical-based therapeutic approaches to combat the pathogenesis of Huntington’s disease

  2022cites this paper
• Effect of Different Levels of 2, 4 Dinitrophenol and Luteolin on Semen Quality of Rooster during Freezing-Thawing Process

  2021cites this paper
• Deciphering the Potential Neuroprotective Effects of Luteolin against Aβ1–42-Induced Alzheimer’s Disease

  2021cites this paper
• Luteolin mitigates potassium dichromate‐induced nephrotoxicity, cardiotoxicity and genotoxicity through modulation of Kim‐1/Nrf2 signaling pathways

  2021cites this paper
• Nutraceutical regulation of miRNAs involved in neurodegenerative diseases and brain cancers

  2021cites this paper
• Healthy ageing and Mediterranean diet: a focus on hormetic phytochemicals.

  2021cites this paper
• Paving Luteolin Therapeutic Potentialities and Agro-Food-Pharma Applications: Emphasis on In Vivo Pharmacological Effects and Bioavailability Traits

  2021cites this paper
• Canine atopic dermatitis: Role of luteolin as new natural treatment

  2020cites this paper
• An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events

  2020cites this paper
• Polyphenols and Other Bioactive Compounds of Sideritis Plants and Their Potential Biological Activity

  2020cites this paper
• The modulatory effects of luteolin on cyclic AMP/Ciliary neurotrophic factor signaling pathway in experimentally induced autoimmune encephalomyelitis

  2019cites this paper
• Korean Thistle (Cirsium japonicum var. maackii (Maxim.) Matsum.): A Potential Dietary Supplement against Diabetes and Alzheimer’s Disease

  2019cites this paper
• Protective effects of Cirsium japonicum var. maackii against amyloid beta-induced neurotoxicity in C6 glial cells

  2019cites this paper
• Effects of Carpobrotus edulis Extract on Oxidative Stress and 158N Oligodendrocyte Death.

  2019cites this paper
• Bioavailability and Pharmaco-therapeutic potential of luteolin in overcoming Alzheimer's disease.

  2019cites this paper
• Biophenols: Impacts and Prospects in Anti-Alzheimer Drug Discovery

  2018cites this paper
• Epigenetic modulation by small molecule compounds for neurodegenerative disorders

  2018cites this paper
• Jobelyn suppresses hippocampal neuronal apoptosis and necrosis in experimental alcohol-induced brain stress.

  2018cites this paper
• The Flavone Luteolin Improves Central Nervous System Disorders by Different Mechanisms: A Review

  2018cites this paper
• Attenuation of Morphine Withdrawal Syndrome by Prosopis Farcta Extract and Its Bioactive Component Luteolin in Comparison with Clonidine in Rats

  2018cites this paper
• Molecular Targets of Tannic Acid in Alzheimer's Disease.

  2017cites this paper
• The effects of Chinese medicines on cAMP/PKA signaling in central nervous system dysfunction.

  2017cites this paper
• Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer’s Mouse Model

  2017cites this paper
• Nutraceuticals and Cognitive Dysfunction

  2017cites this paper
• Neuroprotective Effect of Bacopa Monnieri Extract on Oxidized Low Density Lipoprotein-Induced Neurotoxicity in SH-SY5Y Neuroblastoma Cells

  2017cites this paper
• Mechanistic comparison of current pharmacological treatments and novel phytochemicals to target amyloid peptides in Alzheimer’s and neurodegenerative diseases

  2017cites this paper
• Biophenols pharmacology against the amyloidogenic activity in Alzheimer's disease.

  2017cites this paper
• Protection of Cultured Cortical Neurons by Luteolin against Oxidative Damage through Inhibition of Apoptosis and Induction of Heme Oxygenase-1.

  2017cites this paper
• Luteolin: A Flavonoid that Has Multiple Cardio-Protective Effects and Its Molecular Mechanisms

  2017cites this paper
• Can Co-Activation of Nrf2 and Neurotrophic Signaling Pathway Slow Alzheimer’s Disease?

  2017cites this paper
• Screening of plants used in the European traditional medicine to treat memory disorders for acetylcholinesterase inhibitory activity and anti amyloidogenic activity.

  2017cites this paper
• Satureja bachtiarica ameliorate beta-amyloid induced memory impairment, oxidative stress and cholinergic deficit in animal model of Alzheimer’s disease

  2016cites this paper
• Bioactive Compounds and Their Neuroprotective Effects in Diabetic Complications

  2016cites this paper
• Estudio in vitro de la capacidad antiglicante y mecanismo de acción de subproductos agroalimentarios. Obtención de un extracto vegetal antiglicante y su evaluación en una matriz alimentaria y modelo celular

  2016cites this paper
• Another promise against ischemia reperfusion injury: every success raises new questions.

  2016cites this paper
• Luteolin and Apigenin Attenuate 4-Hydroxy-2-Nonenal-Mediated Cell Death through Modulation of UPR, Nrf2-ARE and MAPK Pathways in PC12 Cells

  2015cites this paper
• Pharmacology of Olive Biophenols in Alzheimer's Disease Prevention and Treatment

  2015cites this paper
• Protective effects of 3-alkyl luteolin derivatives are mediated by Nrf2 transcriptional activity and decreased oxidative stress in Huntington's disease mouse striatal cells.

  2015cites this paper
• Luteolin as an anti-inflammatory and neuroprotective agent: A brief review.

  2015cites this paper
• Up-Regulation of miR-34a Expression in Response to the Luteolin-Induced Neurite Outgrowth of PC12 Cells.

  2015cites this paper
• Adaptive Cellular Stress Pathways as Therapeutic Targets of Dietary Phytochemicals: Focus on the Nervous System

  2014cites this paper
• Nutraceuticals in cognitive impairment and Alzheimer’s disease

  2014cites this paper
• Dietary polyphenols for treatment of Alzheimer's disease--future research and development.

  2014cites this paper
• Luteolin Modulates 6-Hydroxydopamine-Induced Transcriptional Changes of Stress Response Pathways in PC12 Cells

  2014cites this paper
• Protective effect of luteolin on an oxidative-stress model induced by microinjection of sodium nitroprusside in mice.

  2013cites this paper
• Protective Effect of Luteolin against β-Amyloid-induced Cell Death and Damage in BV-2 Microglial Cells

  2013cites this paper
• Protective effects of luteolin on cognitive impairments induced by psychological stress in mice

  2013cites this paper
• Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs

  2013cites this paper
• ERK/PP1a/PLB/SERCA2a and JNK Pathways Are Involved in Luteolin-Mediated Protection of Rat Hearts and Cardiomyocytes following Ischemia/Reperfusion

  2013cites this paper
• 8th Annual Conference of the European Nutraceutical Association (ENA)

  2012cites this paper
• Houttuyniae Herba protects rat primary cortical cells from Aβ25–35-induced neurotoxicity via regulation of calcium influx and mitochondria-mediated apoptosis

  2012cites this paper
• Luteolin Induces microRNA-132 Expression and Modulates Neurite Outgrowth in PC12 Cells

  2012cites this paper
• Luteolin enhances cholinergic activities in PC12 cells through ERK1/2 and PI3K/Akt pathways.

  2012cites this paper
• Pharmacokinetic study of luteolin, apigenin, chrysoeriol and diosmetin after oral administration of Flos Chrysanthemi extract in rats

  2012cites this paper
• MS Oh of calcium influx and mitochondria-mediated apoptosis-induced neurotoxicity via regulation 35 − 25 β Houttuyniae Herba protects rat primary cortical cells from A

  2012cites this paper
• Targeting Cell Signaling and Apoptotic Pathways by Luteolin: Cardioprotective Role in Rat Cardiomyocytes Following Ischemia/Reperfusion

  2012cites this paper
• Protective effects of some medicinal plants from Lamiaceae family against beta-amyloid induced toxicity in PC12 cell

  2012cites this paper
• Luteolin inhibits the release of glutamate in rat cerebrocortical nerve terminals.

  2011cites this paper
• Luteolin Isolated from the Medicinal Plant Elsholtzia rugulosa (Labiatae) Prevents Copper-Mediated Toxicity in β-Amyloid Precursor Protein Swedish Mutation Overexpressing SH-SY5Y Cells

  2011cites this paper
• Plants and their chemical compounds affecting β-amyloid and secretase activity as potential sources of neuroprotective herbal medicinal products. Part 1.

  2010cites this paper
• Neurotrophic and cytoprotective action of luteolin in PC12 cells through ERK-dependent induction of Nrf2-driven HO-1 expression.

  2010cites this paper